Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Dix

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|November 3, 2012
Utility of anti-xa monitoring in children receiving enoxaparin for therapeutic anticoagulationMarianna Leung, Sharon H Ho, Donald P Hamilton, et al.
The New England Journal of Medicine|June 29, 2022
Nonoperative Management of Childhood Calvarial Langerhans-Cell HistiocytosisPaul Steinbok, Alexander Cheong, David B Dix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2018
Reply to D.M. GreenDavid B Dix, Nita L Seibel, Yueh-Yun Chi, et al.
Pediatric Blood & Cancer|October 30, 2013
A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapyGeoff D E Cuvelier, Tina J Baker, Elaine F Peddie, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2022
Authors' Reply to the Letter to the Editor by Daniel M. GreenJeffrey S Dome, Elizabeth A Mullen, David B Dix, et al.
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: renal tumorsJeffrey S Dome, Conrad V Fernandez, Elizabeth A Mullen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 20, 2021
Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms TumorJeffrey S Dome, Elizabeth A Mullen, David B Dix, et al.
Cancer|November 7, 2023
Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5Daniel J Benedetti, Carly R Varela, Lindsay A Renfro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2018
Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 StudyDavid B Dix, Nita L Seibel, Yueh-Yun Chi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2019
Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study ReportDavid B Dix, Conrad V Fernandez, Yueh-Yun Chi, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|November 3, 2012
Utility of anti-xa monitoring in children receiving enoxaparin for therapeutic anticoagulationMarianna Leung, Sharon H Ho, Donald P Hamilton, et al.
The New England Journal of Medicine|June 29, 2022
Nonoperative Management of Childhood Calvarial Langerhans-Cell HistiocytosisPaul Steinbok, Alexander Cheong, David B Dix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2018
Reply to D.M. GreenDavid B Dix, Nita L Seibel, Yueh-Yun Chi, et al.
Pediatric Blood & Cancer|October 30, 2013
A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapyGeoff D E Cuvelier, Tina J Baker, Elaine F Peddie, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2022
Authors' Reply to the Letter to the Editor by Daniel M. GreenJeffrey S Dome, Elizabeth A Mullen, David B Dix, et al.
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: renal tumorsJeffrey S Dome, Conrad V Fernandez, Elizabeth A Mullen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 20, 2021
Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms TumorJeffrey S Dome, Elizabeth A Mullen, David B Dix, et al.
Cancer|November 7, 2023
Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5Daniel J Benedetti, Carly R Varela, Lindsay A Renfro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2018
Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 StudyDavid B Dix, Nita L Seibel, Yueh-Yun Chi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2019
Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study ReportDavid B Dix, Conrad V Fernandez, Yueh-Yun Chi, et al.
Pageof 3